{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:43Z","timestamp":1792788343236,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Foundation Tokyohokenkai Byoutaiseiri Laboratories","award":["Subsidy No. 201"],"award-info":[{"award-number":["Subsidy No. 201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-024-04889-2","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T06:25:23Z","timestamp":1734675923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Harukazu","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"4889_CR1","unstructured":"World Health Organization. Coronavirus (COVID-19) data. https:\/\/www.who.int\/. Accessed 10 March 2024."},{"key":"4889_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et\u00a0al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603\u201315.","journal-title":"N Engl J Med"},{"key":"4889_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12941-023-00594-y","volume":"22","author":"M Soheili","year":"2023","unstructured":"Soheili M, Khateri S, Moradpour F, Mohammadzedeh P, Zareie M, Mortazavi SMM, et\u00a0al. The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis. Ann Clin Microbiol Antimicrob. 2023;22:42.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4889_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40246-020-00290-4","volume":"14","author":"C Anastassopoulou","year":"2020","unstructured":"Anastassopoulou C, Gkizarioti Z, Patrinos GP, Tsakris A. Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics. 2020;14:40.","journal-title":"Hum Genomics"},{"key":"4889_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s43587-024-00644-w","volume":"4","author":"B Dallan","year":"2024","unstructured":"Dallan B, Proietto D, De Laurentis M, Gallerani E, Martino M, Ghisellini S, et\u00a0al. Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19. Nat Aging. 2024;4:1121\u201336.","journal-title":"Nat Aging"},{"key":"4889_CR6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/diagnostics11071135","volume":"11","author":"B Lo Sasso","year":"2021","unstructured":"Lo Sasso B, Giglio RV, Vidali M, Scazzone C, Bivona G, Gambino CM, et\u00a0al. Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine. Diagnostics. 2021;11:1135.","journal-title":"Diagnostics"},{"key":"4889_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01746-21","volume":"60","author":"K Saker","year":"2022","unstructured":"Saker K, Escuret V, Pitiot V, Massardier-Pilonch\u00e9ry A, Paul S, Mokdad B, et\u00a0al. Evaluation of commercial anti-SARS-CoV-2 antibody assays and comparison of standardized titers in vaccinated health care workers. J Clin Microbiol. 2022;60: e0174621.","journal-title":"J Clin Microbiol"},{"key":"4889_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abp8328","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tong P, Whiteman N, Sanjari Moghaddam A, Zarghami M, Zuiani A, et\u00a0al. Immune recall improves antibody durability and breadth to SARS-CoV-2 variants. Sci Immunol. 2022. https:\/\/doi.org\/10.1126\/sciimmunol.abp8328.","journal-title":"Sci Immunol"},{"key":"4889_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41591-022-01721-6","volume":"28","author":"J Wei","year":"2022","unstructured":"Wei J, Pouwels KB, Stoesser N, Matthews PC, Diamond I, Studley R, et\u00a0al. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat Med. 2022;28:1072\u201382.","journal-title":"Nat Med"},{"key":"4889_CR10","doi-asserted-by":"publisher","first-page":"1097747","DOI":"10.3389\/fimmu.2023.1097747","volume":"14","author":"FJ Cimas","year":"2023","unstructured":"Cimas FJ, Torres J, Onta\u00f1\u00f3n J, de Cabo C, Lozano J, Requena M\u00c1, et\u00a0al. Mathematical modelling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination. Front Immunol. 2023;14:1097747.","journal-title":"Front Immunol"},{"key":"4889_CR11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","volume":"22","author":"APS Munro","year":"2022","unstructured":"Munro APS, Feng S, Janani L, Cornelius V, Aley PK, Babbage G, et\u00a0al. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Lancet Infect Dis. 2022;22:1131\u201341.","journal-title":"Lancet Infect Dis"},{"key":"4889_CR12","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/j.jinf.2022.09.018","volume":"86","author":"MJ Choi","year":"2023","unstructured":"Choi MJ, Choi JY, Hyun H, Nham E, Seong H, Yoon JG, et\u00a0al. Cross-neutralization of omicron subvariants after heterologous NVX-CoV2373 boosters: comparison between prior SARS-CoV-2-infected and infection-naive individuals. J Infect. 2023;86:e46\u20138.","journal-title":"J Infect"},{"key":"4889_CR13","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.1016\/j.vaccine.2021.10.038","volume":"39","author":"J Khoury","year":"2021","unstructured":"Khoury J, Najjar-Debbiny R, Hanna A, Jabbour A, Abu Ahmad Y, Saffuri A, et\u00a0al. COVID-19 vaccine \u2013 long term immune decline and breakthrough infections. Vaccine. 2021;39:6984\u20139.","journal-title":"Vaccine"},{"key":"4889_CR14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jiac.2022.02.024","volume":"28","author":"H Ikezaki","year":"2022","unstructured":"Ikezaki H, Nomura H, Shimono N. Dynamics of anti-spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers. J Infect Chemother. 2022;28:802\u20135.","journal-title":"J Infect Chemother"},{"key":"4889_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijid.2021.09.073","volume":"113","author":"M Kruse","year":"2021","unstructured":"Kruse M, Dark C, Aspden M, Cochrane D, Competiello R, Peltz M, et\u00a0al. Performance of the T-SPOT\u24c7.COVID test for detecting SARS-CoV-2-responsive T cells. Int J Infect Dis. 2021;113:155\u201361.","journal-title":"Int J Infect Dis"},{"key":"4889_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo1303","author":"S Vardhana","year":"2022","unstructured":"Vardhana S, Baldo L, Morice WG, Wherry EJ. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022. https:\/\/doi.org\/10.1126\/sciimmunol.abo1303.","journal-title":"Sci Immunol"},{"key":"4889_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726960","volume":"12","author":"S Gil-Manso","year":"2021","unstructured":"Gil-Manso S, Carbonell D, L\u00f3pez-Fern\u00e1ndez L, Miguens I, Alonso R, Bu\u00f1o I, et\u00a0al. Induction of high levels of specific humoral and cellular responses to SARS-CoV-2 after the administration of Covid-19 mRNA vaccines requires several days. Front Immunol. 2021;12: 726960.","journal-title":"Front Immunol"},{"key":"4889_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05131-22","author":"H Kawasuji","year":"2023","unstructured":"Kawasuji H, Morinaga Y, Tani H, Saga Y, Yamada H, Yoshida Y, et\u00a0al. Neutralizing antibody response of the wild-type\/Omicron BA1 bivalent vaccine as the second booster dose against Omicron BA2 and BA5. Microbiol Spectr. 2023. https:\/\/doi.org\/10.1128\/spectrum.05131-22.","journal-title":"Microbiol Spectr"},{"key":"4889_CR19","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMc2211283","volume":"387","author":"M Canetti","year":"2022","unstructured":"Canetti M, Barda N, Gilboa M, Indenbaum V, Asraf K, Gonen T, et\u00a0al. Six-month follow-up after a fourth BNT162b2 vaccine dose. N Engl J Med. 2022;387:2092\u20134.","journal-title":"N Engl J Med"},{"key":"4889_CR20","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","volume":"185","author":"RR Goel","year":"2022","unstructured":"Goel RR, Painter MM, Lundgreen KA, Apostolidis SA, Baxter AE, Giles JR, et\u00a0al. Efficient recall of omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell. 2022;185:1875\u201387.","journal-title":"Cell"},{"key":"4889_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.26.23294679v1","author":"K Srivastava","year":"2023","unstructured":"Srivastava K, Carreno Quiroz JM, Gleason C, Monahan B, Singh G, Abbad A, et\u00a0al. Kinetics and durability of humoral responses to SARS-CoV-2 infection and vaccination. Medrxiv. 2023. https:\/\/doi.org\/10.1101\/2023.08.26.23294679v1.","journal-title":"Medrxiv"},{"key":"4889_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205598119","volume":"119","author":"M Van Beek","year":"2022","unstructured":"Van Beek M, Nussenzweig MC, Chakraborty AK. Two complementary features of humoral immune memory confer protection against the same or variant antigens. Proc Natl Acad Sci U S A. 2022;119: e2205598119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4889_CR23","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/eji.201343716","volume":"44","author":"T Takemori","year":"2014","unstructured":"Takemori T, Kaji T, Takahashi Y, Shimoda M, Rajewsky K. Generation of memory B cells inside and outside germinal centers. Eur J Immunol. 2014;44:1258\u201364.","journal-title":"Eur J Immunol"},{"key":"4889_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204607119","volume":"119","author":"L Kardava","year":"2022","unstructured":"Kardava L, Rachmaninoff N, Lau WW, Buckner CM, Trihemasava K, Blazkova J, et\u00a0al. Early human B cell signatures of the primary antibody response to mRNA vaccination. Proc Natl Acad Sci U S A. 2022;119: e2204607119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4889_CR25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et\u00a0al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21:1506\u201316.","journal-title":"Nat Immunol"},{"key":"4889_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et\u00a0al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020;183:143\u201357.","journal-title":"Cell"},{"key":"4889_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1025","volume":"12","author":"T Cao","year":"2022","unstructured":"Cao T, Liu L, To KK, Lim CY, Zhou R, Ming Y, et\u00a0al. Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity. Clin Transl Med. 2022;12: e1025.","journal-title":"Clin Transl Med"},{"key":"4889_CR28","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/s41467-017-01901-w","volume":"8","author":"E Hammarlund","year":"2017","unstructured":"Hammarlund E, Thomas A, Amanna IJ, Holden LA, Slayden OD, Park B, et\u00a0al. Plasma cell survival in the absence of B cell memory. Nat Commun. 2017;8:1781.","journal-title":"Nat Commun"},{"key":"4889_CR29","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.4049\/jimmunol.2200525","volume":"209","author":"S Mise-Omata","year":"2022","unstructured":"Mise-Omata S, Ikeda M, Takeshita M, Uwamino Y, Wakui M, Arai T, et\u00a0al. Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and responsiveness to the Omicron variant. J Immunol. 2022;209:2104\u201313.","journal-title":"J Immunol"},{"key":"4889_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157990","volume":"132","author":"A Mazzoni","year":"2022","unstructured":"Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, et\u00a0al. SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies. J Clin Invest. 2022;132: e157990.","journal-title":"J Clin Invest"},{"key":"4889_CR31","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1016\/j.cell.2021.10.011","volume":"184","author":"RP Payne","year":"2021","unstructured":"Payne RP, Longet S, Austin JA, Skelly DT, Dejnirattisai W, Adele S, et\u00a0al. Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell. 2021;184:5699-5714.e11.","journal-title":"Cell"},{"key":"4889_CR32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJMc2202542","volume":"386","author":"G Regev-Yochay","year":"2022","unstructured":"Regev-Yochay G, Gonen T, Gilboa M, Mandelboim M, Indenbaum V, Amit S, et\u00a0al. Efficacy of a fourth dose of Covid-19 mRNA vaccine against omicron. N Engl J Med. 2022;386:1377\u201380.","journal-title":"N Engl J Med"},{"key":"4889_CR33","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/vaccines10071050","volume":"10","author":"K Yamashita","year":"2022","unstructured":"Yamashita K, Suzuki A, Takebayashi S, Toguchi A, Ogitani K, Niizeki N, et\u00a0al. Differential dynamics of humoral and cell-mediated immunity with three doses of BNT162b2 SARS-CoV-2 vaccine in healthcare workers in Japan: a prospective cohort study. Vaccines. 2022;10:1050.","journal-title":"Vaccines"},{"key":"4889_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110235","volume":"38","author":"R Lozano-Rodr\u00edguez","year":"2022","unstructured":"Lozano-Rodr\u00edguez R, Valent\u00edn-Quiroga J, Avenda\u00f1o-Ortiz J, Mart\u00edn-Quir\u00f3s A, Pascual-Iglesias A, Terr\u00f3n-Arcos V, et\u00a0al. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell Rep. 2022;38: 110235.","journal-title":"Cell Rep"},{"key":"4889_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/infdis\/jiac344","volume":"227","author":"K Miyakawa","year":"2023","unstructured":"Miyakawa K, Kato H, Ohtake N, Jeremiah SS, Ryo A. Enhancement of humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 by a third dose of BNT162b2 vaccine in Japanese healthcare workers. J Infect Dis. 2023;227:221\u20135.","journal-title":"J Infect Dis"},{"key":"4889_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","volume":"3","author":"N Jo","year":"2023","unstructured":"Jo N, Hidaka Y, Kikuchi O, Fukahori M, Sawada T, Aoki M, et\u00a0al. Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nat Aging. 2023;3:82\u201392.","journal-title":"Nat Aging"},{"key":"4889_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13692","volume":"21","author":"JL Lee","year":"2022","unstructured":"Lee JL, Fra-Bido SC, Burton AR, Innocentin S, Hill DL, Linterman MA. B cell-intrinsic changes with age do not impact antibody-secreting cell formation but delay B cell participation in the germinal centre reaction. Aging Cell. 2022;21: e13692.","journal-title":"Aging Cell"},{"key":"4889_CR38","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.20090896","volume":"206","author":"E Agius","year":"2009","unstructured":"Agius E, Lacy KE, Vukmanovic-Stejic M, Jagger AL, Papageorgiou AP, Hall S, et\u00a0al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med. 2009;206:1929\u201340.","journal-title":"J Exp Med"},{"key":"4889_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010085","volume":"17","author":"R Uraki","year":"2021","unstructured":"Uraki R, Imai M, Ito M, Shime H, Odanaka M, Okuda M, et\u00a0al. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens. PLOS Pathog. 2021;17: e1010085.","journal-title":"PLOS Pathog"},{"key":"4889_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99712","volume":"3","author":"M Doebbeler","year":"2018","unstructured":"Doebbeler M, Koenig C, Krzyzak L, Seitz C, Wild A, Ulas T, et\u00a0al. CD83 expression is essential for Treg cell differentiation and stability. JCI Insight. 2018;3: e99712.","journal-title":"JCI Insight"},{"key":"4889_CR41","doi-asserted-by":"publisher","first-page":"17621","DOI":"10.1038\/s41598-022-22682-3","volume":"12","author":"T Chano","year":"2022","unstructured":"Chano T, Yamashita T, Fujimura H, Kita H, Ikemoto T, Kume S, et\u00a0al. Effectiveness of COVID-19 vaccination in healthcare workers in Shiga prefecture. Japan Sci Rep. 2022;12:17621.","journal-title":"Japan Sci Rep"},{"key":"4889_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.965971","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Liu S, Li F, Li Y, Li Y, Peng P, et\u00a0al. Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis. Front Immunol. 2022;13: 965971.","journal-title":"Front Immunol"},{"key":"4889_CR43","doi-asserted-by":"publisher","first-page":"1113156","DOI":"10.3389\/fimmu.2023.1113156","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu K, Wang Z, Qin M, Gao Y, Luo N, Xie W, et\u00a0al. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults. Front Immunol. 2023;14:1113156.","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"4889_CR44","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1093\/cid\/ciac302","volume":"75","author":"E Nanishi","year":"2022","unstructured":"Nanishi E, Angelidou A, Rotman C, Dowling DJ, Levy O, Ozonoff A. Precision vaccine adjuvants for older adults: a scoping review. Clin Infect Dis. 2022;75(Suppl 1):S72\u201380.","journal-title":"Clin Infect Dis"},{"key":"4889_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.vaccine.2024.07.018","volume":"42","author":"K Steenackers","year":"2024","unstructured":"Steenackers K, Hanning N, Bruckers L, Desombere I, Marchant A, Ari\u00ebn KK, et\u00a0al. Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: the IMCOVAS randomized clinical trial. Vaccine. 2024;42:25.","journal-title":"Vaccine"},{"issue":"16","key":"4889_CR46","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1016\/j.vaccine.2024.04.059","volume":"42","author":"V C\u00e1rdenas","year":"2024","unstructured":"C\u00e1rdenas V, Le Gars M, Truyers C, Ruiz-Gui\u00f1az\u00fa J, Struyf F, Colfer A, et\u00a0al. Safety and immunogenicity of Ad26.COV2.S in adults: a randomised, double-blind, placebo-controlled Phase 2a dose-finding study. Vaccine. 2024;42(16):3536\u201346.","journal-title":"Vaccine"},{"key":"4889_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107084","volume":"145","author":"DY Lin","year":"2024","unstructured":"Lin DY, Xu Y, Gu Y, Sunny SK, Moore Z, Zeng D. Impact of booster vaccination interval on SARS-CoV-2 infection, hospitalization, and death. Int J Infect Dis. 2024;145: 107084.","journal-title":"Int J Infect Dis"},{"issue":"10303","key":"4889_CR48","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","volume":"398","author":"X Liu","year":"2021","unstructured":"Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, et\u00a0al. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021;398(10303):856\u201369.","journal-title":"Lancet"},{"key":"4889_CR49","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/s41467-024-47429-8","volume":"15","author":"R Urschel","year":"2024","unstructured":"Urschel R, Bronder S, Klemis V, Marx S, Hielscher F, Abu-Omar A, et\u00a0al. SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4\/5 COVID-19-vaccination in previously infected and non-infected individuals. Nat Commun. 2024;15:3077.","journal-title":"Nat Commun"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04889-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:04:59Z","timestamp":1734678299000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4889"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04889-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Fukui Health Cooperative Association Ethics Committee in February 2021 (approval number F21002). All research procedures were conducted in accordance with the principles of the Declaration of Helsinki. Written, voluntary informed consent to participate in the study was obtained from the participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"631"}}